Lacnotuzumab

• Target :

  C-Fms

• Related Pathways :

  Tyrosine Kinase/Adaptors

• Purity :

  0.9936

• Bioactivity :

  Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, inhibiting the macrophage colony-stimulating factor pathway upstream components, used in retinal disease research.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1831128-32-5